OTC Zantac And Private Label Ranitidine Numerous In FDA Recall Updates

12 Jan 2020

In addition to Sanofi, firms recalling OTC ranitidine products with documentation included in FDA's database updates through 9 January are Amneal Pharmaceuticals, Preferred Pharmaceuticals, which distributed products made by Amneal, and Granules India Ltd.

Product Recall, man writing on transparent screen - Image

Sanofi's recall of OTC Zantac due to contamination of the active ingredient ranitidine with a potential carcinogenic is so widespread the US Food and Drug Administration's documentation of the firm's actions doesn't identify quantities of containers or packages but refers only to "all lots" of the products.

Information on some other firms' recalls for private label and store brand copies of OTC Zantac in 75- and 150-mg...